These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 383278

  • 1. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.
    Ertel IJ, Nesbit ME, Hammond D, Weiner J, Sather H.
    Cancer Res; 1979 Oct; 39(10):3893-6. PubMed ID: 383278
    [Abstract] [Full Text] [Related]

  • 2. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
    Nesbit ME, Ertel I, Hammond GD.
    Cancer Treat Rep; 1981 Oct; 65 Suppl 4():101-7. PubMed ID: 7049373
    [Abstract] [Full Text] [Related]

  • 3. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA, Nesbit ME, Donaldson MH, Hittle RE, Weiner J, Karon M, Hammond D.
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
    Nesbit ME, Sather H, Robison LL, Donaldson M, Littman P, Ortega JA, Hammond GD.
    Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
    [Abstract] [Full Text] [Related]

  • 7. Immunological aspects of L-asparaginase treatment in children with lymphoproliferative disease.
    Zajaczkowski J, Pituch A, Legutko L, Pajak E.
    Helv Paediatr Acta; 1976 Jan; 30(4-5):441-6. PubMed ID: 1060605
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 9. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
    van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, Rammeloo JA, de Koning J, van Zanen GE.
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):61-6. PubMed ID: 3287685
    [Abstract] [Full Text] [Related]

  • 10. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
    Sallan SE, Hitchcock-Bryan S, Gelber R, Cassady JR, Frei E, Nathan DG.
    Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.
    Capizzi RL.
    Cancer Treat Rep; 1981 Nov; 65 Suppl 4():115-21. PubMed ID: 7049375
    [Abstract] [Full Text] [Related]

  • 13. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.
    Holland JF, Ohnuma T.
    Cancer Treat Rep; 1981 Nov; 65 Suppl 4():123-30. PubMed ID: 7049376
    [Abstract] [Full Text] [Related]

  • 14. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
    Poplack DG, Reaman GH, Wesley R.
    Cancer Treat Rep; 1981 Nov; 65 Suppl 4():93-6. PubMed ID: 6955015
    [Abstract] [Full Text] [Related]

  • 15. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
    Cáp J, Koza I, Misíková Z, Foltinová A, Strbáková E.
    Neoplasma; 1983 Nov; 30(1):81-92. PubMed ID: 6339961
    [Abstract] [Full Text] [Related]

  • 16. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD.
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP, Preisler HD, Slocum H, Rustum YM.
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
    Pession A, Valsecchi MG, Masera G, Kamps WA, Magyarosy E, Rizzari C, van Wering ER, Lo Nigro L, van der Does A, Locatelli F, Basso G, Aricò M.
    J Clin Oncol; 2005 Oct 01; 23(28):7161-7. PubMed ID: 16192600
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
    Amato KR, Sallan SE, Lipton JM.
    Cancer Treat Rep; 1984 Feb 01; 68(2):411-2. PubMed ID: 6583001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.